ATLANTA, GA--(Marketwire - January 03, 2008) - AtheroGenics, Inc. (NASDAQ: AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today announced that Russell M. Medford, M.D., Ph.D., President and Chief Executive Officer, will be presenting a company overview and update at the upcoming 26th Annual JPMorgan Healthcare Conference on Thursday, January 10, 2008, at 10:00 a.m. PT at the Westin St. Francis in San Francisco, CA.
